がん支持療法の世界市場 2023-2027年

当レポートでは、がん支持療法の市場規模は、2022年から2027年の間に65億6392万米ドル、予測期間中のCAGRは4.62%で成長すると予測しています。

当レポートでは、がん支持療法市場の全体的な分析、市場規模と予測、動向、成長促進要因・課題、約25のベンダーを網羅したベンダー分析を行っています。

現在の市場動向と促進要因、市場環境全体に関する最新の分析を提供しています。市場は、がん患者の増加、がん治療に伴う多くの副作用、新興国における未開拓の可能性によって牽引されています。

本調査では、がん関連治療におけるバイオシミラーの登場が、今後数年間のがんサポーティブケア市場の成長を牽引する主要な理由の1つであると位置付けています。また、バイオシミラーの製造活動のアウトソーシングや様々な戦略の採用は、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し：2022-2027年の予測

第4章 市場規模実績

• 世界のがんサポーティブケア市場2017～2021年
• 治療領域セグメント分析2017-2021
• 流通チャネルセグメント分析2017-2021
• 地域セグメント分析2017-2021
• 国セグメント分析2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 治療分野別の市場セグメンテーション

• マーケット・セグメント
• 領域別比較
• 化学療法別貧血 - 市場規模と予測 2022-2027
• 化学療法別好中球減少症 - 市場規模と予測 2022-2027
• がんの痛み - 市場規模と予測 2022-2027
• CINV - 市場規模と予測 2022-2027
• その他 - 市場規模と予測 2022-2027
• 治療領域別の市場機会

第7章 流通チャネル別市場セグメンテーション

• マーケット・セグメント
• 流通チャネル別比較
• 病院の薬局 - 市場規模と予測 2022-2027
• ドラッグストアと小売薬局 - 市場規模と予測 2022-2027
• オンラインプロバイダー - 市場規模と予測 2022-2027
• 流通チャネル別の市場機会

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米 - 市場規模と予測 2022-2027
• 欧州 - 市場規模と予測 2022-2027
• アジア - 市場規模と予測 2022-2027
• その他の地域（ROW） - 市場規模と予測 2022-2027
• 米国 - 市場規模と予測 2022-2027
• 英国 - 市場規模と予測 2022-2027
• ドイツ - 市場規模と予測 2022-2027
• 中国 - 市場規模と予測 2022-2027
• カナダ - 市場規模と予測 2022-2027
• 地域情勢別の市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Amgen Inc.
• Baxter International Inc.
• Bayer AG
• Daiichi Sankyo Co. Ltd.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Heron Therapeutics Inc.
• Johnson and Johnson
• Kyowa Kirin Co. Ltd.
• Merck and Co. Inc.
• Novartis AG
• Purdue Pharma LP
• Sanofi SA
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Therapeutic Area
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global cancer supportive care market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Therapeutic area Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Therapeutic Area - Market share 2022-2027 (%)
• Exhibits31: Data Table on Therapeutic Area - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Therapeutic Area
• Exhibits33: Data Table on Comparison by Therapeutic Area
• Exhibits34: Chart on Chemotherapy-induced anemia - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Chemotherapy-induced anemia - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Chemotherapy-induced anemia - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Chemotherapy-induced anemia - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Chemotherapy-induced neutropenia - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Chemotherapy-induced neutropenia - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Chemotherapy-induced neutropenia - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Chemotherapy-induced neutropenia - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Cancer pain - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Cancer pain - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Cancer pain - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Cancer pain - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on CINV - Market size and forecast 2022-2027 ($ million)
• Exhibits47: Data Table on CINV - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Chart on CINV - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on CINV - Year-over-year growth 2022-2027 (%)
• Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits54: Market opportunity by Therapeutic Area ($ million)
• Exhibits55: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits56: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits57: Chart on Comparison by Distribution Channel
• Exhibits58: Data Table on Comparison by Distribution Channel
• Exhibits59: Chart on Hospitals pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits60: Data Table on Hospitals pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Chart on Hospitals pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits62: Data Table on Hospitals pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits63: Chart on Drug stores and retail pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits64: Data Table on Drug stores and retail pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Chart on Drug stores and retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits66: Data Table on Drug stores and retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits67: Chart on Online providers - Market size and forecast 2022-2027 ($ million)
• Exhibits68: Data Table on Online providers - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Chart on Online providers - Year-over-year growth 2022-2027 (%)
• Exhibits70: Data Table on Online providers - Year-over-year growth 2022-2027 (%)
• Exhibits71: Market opportunity by Distribution Channel ($ million)
• Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits73: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits75: Chart on Geographic comparison
• Exhibits76: Data Table on Geographic comparison
• Exhibits77: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits79: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits80: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits83: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits87: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits94: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits95: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits103: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits105: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits106: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits107: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits108: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits109: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits110: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits111: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits112: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits113: Market opportunity By Geographical Landscape ($ million)
• Exhibits114: Impact of drivers and challenges in 2022 and 2027
• Exhibits115: Overview on Criticality of inputs and Factors of differentiation
• Exhibits116: Overview on factors of disruption
• Exhibits117: Impact of key risks on business
• Exhibits118: Vendors covered
• Exhibits119: Matrix on vendor position and classification
• Exhibits120: Amgen Inc. - Overview
• Exhibits121: Amgen Inc. - Product / Service
• Exhibits122: Amgen Inc. - Key offerings
• Exhibits123: Baxter International Inc. - Overview
• Exhibits124: Baxter International Inc. - Business segments
• Exhibits125: Baxter International Inc. - Key news
• Exhibits126: Baxter International Inc. - Key offerings
• Exhibits127: Baxter International Inc. - Segment focus
• Exhibits128: Bayer AG - Overview
• Exhibits129: Bayer AG - Business segments
• Exhibits130: Bayer AG - Key news
• Exhibits131: Bayer AG - Key offerings
• Exhibits132: Bayer AG - Segment focus
• Exhibits133: Daiichi Sankyo Co. Ltd. - Overview
• Exhibits134: Daiichi Sankyo Co. Ltd. - Business segments
• Exhibits135: Daiichi Sankyo Co. Ltd. - Key news
• Exhibits136: Daiichi Sankyo Co. Ltd. - Key offerings
• Exhibits137: Daiichi Sankyo Co. Ltd. - Segment focus
• Exhibits138: F. Hoffmann La Roche Ltd. - Overview
• Exhibits139: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits140: F. Hoffmann La Roche Ltd. - Key news
• Exhibits141: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits142: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits143: GlaxoSmithKline Plc - Overview
• Exhibits144: GlaxoSmithKline Plc - Business segments
• Exhibits145: GlaxoSmithKline Plc - Key offerings
• Exhibits146: GlaxoSmithKline Plc - Segment focus
• Exhibits147: Heron Therapeutics Inc. - Overview
• Exhibits148: Heron Therapeutics Inc. - Product / Service
• Exhibits149: Heron Therapeutics Inc. - Key news
• Exhibits150: Heron Therapeutics Inc. - Key offerings
• Exhibits151: Johnson and Johnson - Overview
• Exhibits152: Johnson and Johnson - Business segments
• Exhibits153: Johnson and Johnson - Key news
• Exhibits154: Johnson and Johnson - Key offerings
• Exhibits155: Johnson and Johnson - Segment focus
• Exhibits156: Kyowa Kirin Co. Ltd. - Overview
• Exhibits157: Kyowa Kirin Co. Ltd. - Product / Service
• Exhibits158: Kyowa Kirin Co. Ltd. - Key offerings
• Exhibits159: Merck and Co. Inc. - Overview
• Exhibits160: Merck and Co. Inc. - Business segments
• Exhibits161: Merck and Co. Inc. - Key news
• Exhibits162: Merck and Co. Inc. - Key offerings
• Exhibits163: Merck and Co. Inc. - Segment focus
• Exhibits164: Novartis AG - Overview
• Exhibits165: Novartis AG - Business segments
• Exhibits166: Novartis AG - Key offerings
• Exhibits167: Novartis AG - Segment focus
• Exhibits168: Purdue Pharma LP - Overview
• Exhibits169: Purdue Pharma LP - Product / Service
• Exhibits170: Purdue Pharma LP - Key offerings
• Exhibits171: Sanofi SA - Overview
• Exhibits172: Sanofi SA - Business segments
• Exhibits173: Sanofi SA - Key news
• Exhibits174: Sanofi SA - Key offerings
• Exhibits175: Sanofi SA - Segment focus
• Exhibits176: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibits177: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibits178: Sun Pharmaceutical Industries Ltd. - Key offerings
• Exhibits179: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits180: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits181: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits182: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits183: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits184: Inclusions checklist
• Exhibits185: Exclusions checklist
• Exhibits186: Currency conversion rates for US$
• Exhibits187: Research methodology
• Exhibits188: Validation techniques employed for market sizing
• Exhibits189: Information sources
• Exhibits190: List of abbreviations

Technavio has been monitoring the cancer supportive care market and is forecast to grow by $6,563.92 mn during 2022-2027, accelerating at a CAGR of 4.62% during the forecast period. Our report on the cancer supportive care market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer cases, many side effects associated with the cancer treatment, and untapped potential in developing countries.

Technavio's cancer supportive care market is segmented as below:

By Distribution Channel

• Hospitals pharmacies
• Drug stores and retail pharmacies
• Online providers

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advent of biosimilars in cancer-associated treatment as one of the prime reasons driving the cancer supportive care market growth during the next few years. Also, outsourcing of biosimilars manufacturing activities and adoption of various strategies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the cancer supportive care market covers the following areas:

• Cancer supportive care market sizing
• Cancer supportive care market forecast
• Cancer supportive care market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cancer supportive care market vendors that include Acacia Pharma Group Plc, Amgen Inc., Baxter International Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Helsinn Healthcare SA, Heron Therapeutics Inc., Johnson and Johnson, Kyowa Kirin Co. Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma LP, RELIEF THERAPEUTICS Holding SA, Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the cancer supportive care market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapeutic Area
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global cancer supportive care market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global cancer supportive care market 2017 - 2021 ($ million)
• 4.2 Therapeutic area Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Therapeutic area Segment 2017 - 2021 ($ million)
• 4.3 Distribution channel Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapeutic Area

• 6.1 Market segments
• Exhibit 30: Chart on Therapeutic Area - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Therapeutic Area - Market share 2022-2027 (%)
• 6.2 Comparison by Therapeutic Area
• Exhibit 32: Chart on Comparison by Therapeutic Area
• Exhibit 33: Data Table on Comparison by Therapeutic Area
• 6.3 Chemotherapy-induced anemia - Market size and forecast 2022-2027
• Exhibit 34: Chart on Chemotherapy-induced anemia - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Chemotherapy-induced anemia - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Chemotherapy-induced anemia - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Chemotherapy-induced anemia - Year-over-year growth 2022-2027 (%)
• 6.4 Chemotherapy-induced neutropenia - Market size and forecast 2022-2027
• Exhibit 38: Chart on Chemotherapy-induced neutropenia - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Chemotherapy-induced neutropenia - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Chemotherapy-induced neutropenia - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Chemotherapy-induced neutropenia - Year-over-year growth 2022-2027 (%)
• 6.5 Cancer pain - Market size and forecast 2022-2027
• Exhibit 42: Chart on Cancer pain - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Cancer pain - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Cancer pain - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Cancer pain - Year-over-year growth 2022-2027 (%)
• 6.6 CINV - Market size and forecast 2022-2027
• Exhibit 46: Chart on CINV - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on CINV - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on CINV - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on CINV - Year-over-year growth 2022-2027 (%)
• 6.7 Others - Market size and forecast 2022-2027
• Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 6.8 Market opportunity by Therapeutic Area
• Exhibit 54: Market opportunity by Therapeutic Area ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 55: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 56: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 57: Chart on Comparison by Distribution Channel
• Exhibit 58: Data Table on Comparison by Distribution Channel
• 7.3 Hospitals pharmacies - Market size and forecast 2022-2027
• Exhibit 59: Chart on Hospitals pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Hospitals pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Hospitals pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Hospitals pharmacies - Year-over-year growth 2022-2027 (%)
• 7.4 Drug stores and retail pharmacies - Market size and forecast 2022-2027
• Exhibit 63: Chart on Drug stores and retail pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Drug stores and retail pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Drug stores and retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Drug stores and retail pharmacies - Year-over-year growth 2022-2027 (%)
• 7.5 Online providers - Market size and forecast 2022-2027
• Exhibit 67: Chart on Online providers - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Online providers - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Online providers - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Online providers - Year-over-year growth 2022-2027 (%)
• 7.6 Market opportunity by Distribution Channel
• Exhibit 71: Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 75: Chart on Geographic comparison
• Exhibit 76: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 UK - Market size and forecast 2022-2027
• Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 China - Market size and forecast 2022-2027
• Exhibit 105: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.11 Canada - Market size and forecast 2022-2027
• Exhibit 109: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 110: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 111: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 112: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 113: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 114: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 116: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 117: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 118: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 119: Matrix on vendor position and classification
• 12.3 Amgen Inc.
• Exhibit 120: Amgen Inc. - Overview
• Exhibit 121: Amgen Inc. - Product / Service
• Exhibit 122: Amgen Inc. - Key offerings
• 12.4 Baxter International Inc.
• Exhibit 123: Baxter International Inc. - Overview
• Exhibit 124: Baxter International Inc. - Business segments
• Exhibit 125: Baxter International Inc. - Key news
• Exhibit 126: Baxter International Inc. - Key offerings
• Exhibit 127: Baxter International Inc. - Segment focus
• 12.5 Bayer AG
• Exhibit 128: Bayer AG - Overview
• Exhibit 129: Bayer AG - Business segments
• Exhibit 130: Bayer AG - Key news
• Exhibit 131: Bayer AG - Key offerings
• Exhibit 132: Bayer AG - Segment focus
• 12.6 Daiichi Sankyo Co. Ltd.
• Exhibit 133: Daiichi Sankyo Co. Ltd. - Overview
• Exhibit 134: Daiichi Sankyo Co. Ltd. - Business segments
• Exhibit 135: Daiichi Sankyo Co. Ltd. - Key news
• Exhibit 136: Daiichi Sankyo Co. Ltd. - Key offerings
• Exhibit 137: Daiichi Sankyo Co. Ltd. - Segment focus
• 12.7 F. Hoffmann La Roche Ltd.
• Exhibit 138: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 139: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 140: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 141: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 142: F. Hoffmann La Roche Ltd. - Segment focus
• 12.8 GlaxoSmithKline Plc
• Exhibit 143: GlaxoSmithKline Plc - Overview
• Exhibit 144: GlaxoSmithKline Plc - Business segments
• Exhibit 145: GlaxoSmithKline Plc - Key offerings
• Exhibit 146: GlaxoSmithKline Plc - Segment focus
• 12.9 Heron Therapeutics Inc.
• Exhibit 147: Heron Therapeutics Inc. - Overview
• Exhibit 148: Heron Therapeutics Inc. - Product / Service
• Exhibit 149: Heron Therapeutics Inc. - Key news
• Exhibit 150: Heron Therapeutics Inc. - Key offerings
• 12.10 Johnson and Johnson
• Exhibit 151: Johnson and Johnson - Overview
• Exhibit 152: Johnson and Johnson - Business segments
• Exhibit 153: Johnson and Johnson - Key news
• Exhibit 154: Johnson and Johnson - Key offerings
• Exhibit 155: Johnson and Johnson - Segment focus
• 12.11 Kyowa Kirin Co. Ltd.
• Exhibit 156: Kyowa Kirin Co. Ltd. - Overview
• Exhibit 157: Kyowa Kirin Co. Ltd. - Product / Service
• Exhibit 158: Kyowa Kirin Co. Ltd. - Key offerings
• 12.12 Merck and Co. Inc.
• Exhibit 159: Merck and Co. Inc. - Overview
• Exhibit 160: Merck and Co. Inc. - Business segments
• Exhibit 161: Merck and Co. Inc. - Key news
• Exhibit 162: Merck and Co. Inc. - Key offerings
• Exhibit 163: Merck and Co. Inc. - Segment focus
• 12.13 Novartis AG
• Exhibit 164: Novartis AG - Overview
• Exhibit 165: Novartis AG - Business segments
• Exhibit 166: Novartis AG - Key offerings
• Exhibit 167: Novartis AG - Segment focus
• 12.14 Purdue Pharma LP
• Exhibit 168: Purdue Pharma LP - Overview
• Exhibit 169: Purdue Pharma LP - Product / Service
• Exhibit 170: Purdue Pharma LP - Key offerings
• 12.15 Sanofi SA
• Exhibit 171: Sanofi SA - Overview
• Exhibit 172: Sanofi SA - Business segments
• Exhibit 173: Sanofi SA - Key news
• Exhibit 174: Sanofi SA - Key offerings
• Exhibit 175: Sanofi SA - Segment focus
• 12.16 Sun Pharmaceutical Industries Ltd.
• Exhibit 176: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 177: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 178: Sun Pharmaceutical Industries Ltd. - Key offerings
• 12.17 Teva Pharmaceutical Industries Ltd.
• Exhibit 179: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 180: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 181: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 182: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 183: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 184: Inclusions checklist
• Exhibit 185: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 186: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 187: Research methodology
• Exhibit 188: Validation techniques employed for market sizing
• Exhibit 189: Information sources
• 13.5 List of abbreviations
• Exhibit 190: List of abbreviations